Search Results for: MET

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
BLK BLK proto-oncogene, Src family tyrosine kinase
  • RUNX1 regulates transcription of genes involved in BCR signaling
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • Fostamatinib
  • Zanubrutinib
  • Maturity onset diabetes of the young (MODY)
CNR1 cannabinoid receptor 1
  • Class A/1 (Rhodopsin-like receptors)
  • G alpha (i) signalling events
  • Dronabinol
  • Nabilone
  • Ricinoleic Acid
  • SLV319
  • V24343
  • AVE-1625
  • Rimonabant
  • Cannabidiol
  • Propacetamol
  • Otenabant
  • Tetrahydrocannabivarin
  • Medical Cannabis
  • Nabiximols
CTTN cortactin
  • RHO GTPases activate PAKs
  • Clathrin-mediated endocytosis
KDELR2 KDEL endoplasmic reticulum protein retention receptor 2
  • COPI-mediated anterograde transport
  • COPI-dependent Golgi-to-ER retrograde traffic
MAP2K3 mitogen-activated protein kinase kinase 3
  • Oxidative Stress Induced Senescence
  • activated TAK1 mediates p38 MAPK activation
  • Fostamatinib
NF2 neurofibromin 2
  • Regulation of actin dynamics for phagocytic cup formation
  • RHO GTPases activate PAKs
  • Malignant pleural mesothelioma
  • Noonan syndrome and related disorders, including: Noonan syndrome (NS); Leopard syndrome (LS); Noonan syndrome-like with loose anagen hair (NS/LAH); CBL-mutation associated syndrome (CBL); Neurofibromatosis type 1 (NF1); Neurofibromatosis type 2 (NF2); Neurofibromatosis-Noonan syndrome (NFNS); Legius syndrome; Cardiofaciocutaneous syndrome (CFCS); Costello syndrome (CS)
SH2B2 SH2B adaptor protein 2
  • Regulation of KIT signaling
  • Factors involved in megakaryocyte development and platelet production
SHB SH2 domain containing adaptor protein B
  • VEGFA-VEGFR2 Pathway
  • VEGFA-VEGFR2 Pathway
SOCS5 suppressor of cytokine signaling 5
  • Interleukin-4 and Interleukin-13 signaling
  • Neddylation
SPSB1 splA/ryanodine receptor domain and SOCS box containing 1
  • Neddylation
  • Antigen processing: Ubiquitination & Proteasome degradation
TERT telomerase reverse transcriptase
  • Telomere Extension By Telomerase
  • Formation of the beta-catenin:TCF transactivating complex
  • Zidovudine
  • Grn163l
  • Tertomotide
  • Cri du chat syndrome; Cat cry syndrome; Chromosme 5p deletion syndrome
TXK TXK tyrosine kinase
  • FCERI mediated Ca+2 mobilization
  • FCERI mediated Ca+2 mobilization
  • Fostamatinib
  • Zanubrutinib
ZAP70 zeta chain of T cell receptor associated protein kinase 70
  • Translocation of ZAP-70 to Immunological synapse
  • Generation of second messenger molecules
  • Staurosporine
  • Fostamatinib
  • Combined immunodeficiencies (CIDs), including the following nine diseases: X-linked hyper IgM syndrome; CD40 deficiency hyper IgM syndrome; Purine nucleoside phosphorylase (PNP) deficiency; Omenn syndrome; MHC deficiency (HLA-class I); MHC deficiency (HLA-class II); Zap-70 deficiency; p56 Lck deficiency; CD8 deficiency
BAG1 BAG cochaperone 1
  • Regulation of HSF1-mediated heat shock response
  • (2R,3R,4S,5R)-2-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
DAPK3 death associated protein kinase 3
  • Caspase activation via Dependence Receptors in the absence of ligand
  • 2-tert-butyl-9-fluoro-1,6-dihydrobenzo[h]imidazo[4,5-f]isoquinolin-7-one
  • 4-(6-{[(1R)-1-(hydroxymethyl)propyl]amino}imidazo[1,2-b]pyridazin-3-yl)benzoic acid
  • (4R)-7,8-dichloro-1',9-dimethyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile
  • Fostamatinib
GLMN glomulin, FKBP associated protein
  • Antigen processing: Ubiquitination & Proteasome degradation
  • Venous malformations, including: Sporadic venous malformation; Cutaneomucosal venous malformation; Glomuvenous malformation
GRB14 growth factor receptor bound protein 14
  • Tie2 Signaling
LATS2 large tumor suppressor kinase 2
  • Signaling by Hippo
MAP2K5 mitogen-activated protein kinase kinase 5
  • Signalling to ERK5
  • Fostamatinib
MATK megakaryocyte-associated tyrosine kinase
  • Downregulation of ERBB2 signaling
  • Fostamatinib

Page 5 out of 7 pages